物质信息
ID:183235
名称和标识
IUPAC标准名
potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-({[(hydrogen phosphonatooxy)(hydroxy)phosphoryl]oxy}methyl)oxolane-3,4-diol
IUPAC传统名
potassium (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-({[hydrogen phosphonatooxy(hydroxy)phosphoryl]oxy}methyl)oxolane-3,4-diol
别名
ADPAdenosine 5′-diphosphate monopotassium salt dihydrateAdenosine 5′-diphosphate 单钾盐 二水合物
化合物性质
产品相关信息
纯度
≥95%
生物来源
bacterial
药理学性质
相关基因信息
human ... HSP90AA1(3320), P2RY1(5028)
理化性质
外观
crystalline
安全信息
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
德国WGK号
3
保存温度
-20°C
描述信息
Biochem/physiol Actions
P2Y receptor agonist.
Application
Adenosine 5′-diphosphate is a P2Y receptor agonist. Adenosine 5′-diphosphate has been used to study the release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD+) in the rat brain. Adenosine 5′-diphosphate has also been used to compare prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome.
P2Y receptor agonist.
Application
Adenosine 5′-diphosphate is a P2Y receptor agonist. Adenosine 5′-diphosphate has been used to study the release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD+) in the rat brain. Adenosine 5′-diphosphate has also been used to compare prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据